Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LRCX
7. MRK
8. LVS
9. SAP
10. CSX

Go back to Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c

Rockwell Medical Reports Third Quarter 2015 Results

November 9, 2015 4:01 PM EST

WIXOM, Mich., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, reported results for the third quarter of 2015.

Q3 2015 Financial Highlights

Sales were $14.4 million, $0.6 million or 4.6% higher than the third quarter of 2014. Gross profit was $2.5 million, a 10.3% increase over Q3 2014. Gross profit margins increased to 17.4% compared to 16.5% in Q3 2014. SG&A expense was $3.8 million, a decrease of... More